Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DAL NASDAQ:PPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDALDelta Air Lines$62.00+1.2%$58.94$34.74▼$69.98$40.51B1.510.29 million shs5.54 million shsPPHVanEck Pharmaceutical ETF$92.21+0.4%$88.84$77.67▼$95.13$1.24B0.72442,140 shs126,384 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDALDelta Air Lines+4.34%+8.01%+2.15%+10.18%+15.09%PPHVanEck Pharmaceutical ETF-0.04%-1.66%+3.12%+4.51%-2.88%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDALDelta Air Lines$62.00+1.2%$58.94$34.74▼$69.98$40.51B1.510.29 million shs5.54 million shsPPHVanEck Pharmaceutical ETF$92.21+0.4%$88.84$77.67▼$95.13$1.24B0.72442,140 shs126,384 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDALDelta Air Lines+4.34%+8.01%+2.15%+10.18%+15.09%PPHVanEck Pharmaceutical ETF-0.04%-1.66%+3.12%+4.51%-2.88%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDALDelta Air Lines 3.05Buy$71.5316.52% UpsidePPHVanEck Pharmaceutical ETF 2.56Moderate Buy$92.070.06% UpsideCurrent Analyst Ratings BreakdownLatest PPH, DAL, MLC, and AO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/15/2025DALDelta Air LinesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$70.00 ➝ $74.0010/14/2025DALDelta Air LinesRothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price Target$65.00 ➝ $72.0010/13/2025DALDelta Air LinesTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$66.00 ➝ $72.0010/13/2025DALDelta Air LinesJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$70.00 ➝ $74.0010/10/2025DALDelta Air LinesUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$72.00 ➝ $75.0010/10/2025DALDelta Air LinesRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetStrong-Buy$68.00 ➝ $70.0010/10/2025DALDelta Air LinesSanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$71.00 ➝ $74.0010/10/2025DALDelta Air LinesSusquehannaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetPositive$68.00 ➝ $70.0010/10/2025DALDelta Air LinesDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$63.00 ➝ $72.0010/10/2025DALDelta Air LinesHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$69.20 ➝ $73.70(Data available from 10/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDALDelta Air Lines$61.64B0.65$10.53 per share5.83$28.83 per share2.13PPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDALDelta Air Lines$3.46B$7.108.657.411.517.36%23.83%5.14%N/APPHVanEck Pharmaceutical ETFN/AN/A20.21∞N/AN/AN/AN/AN/ALatest PPH, DAL, MLC, and AO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/9/2025Q3 2025DALDelta Air Lines$1.52$1.71+$0.19$2.17$15.79 billion$15.20 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDALDelta Air Lines$0.751.22%N/A10.56%1 YearsPPHVanEck Pharmaceutical ETF$1.932.10%N/AN/AN/ALatest PPH, DAL, MLC, and AO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date9/25/2025DALDelta Air Linesquarterly$0.18751.32%10/16/202510/16/202511/6/20259/30/2025PPHVanEck Pharmaceutical ETFquarterly$0.39311.67%10/1/202510/1/202510/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDALDelta Air Lines0.680.400.34PPHVanEck Pharmaceutical ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDALDelta Air Lines69.93%PPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipDALDelta Air Lines0.96%PPHVanEck Pharmaceutical ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDALDelta Air Lines100,000652.96 million646.70 millionOptionablePPHVanEck Pharmaceutical ETF147,00013.44 millionN/AOptionablePPH, DAL, EZH, and SSTY HeadlinesRecent News About These CompaniesDrug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?October 13 at 6:10 AM | fool.com4 Reasons to Buy Pharma ETFs Now for a Healthy PortfolioOctober 6, 2025 | zacks.comPfizer – TrumpRx deal boosts Big Pharma to a record rallyOctober 4, 2025 | msn.comPharmaceutical ETF on track for best week since 2020October 3, 2025 | marketwatch.com100% Pharmaceutical Tariffs Are Here. Time to Buy These 3 DrugmakersOctober 1, 2025 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.3931October 1, 2025 | msn.comBig Pharma rebounds despite Trump’s latest tariff threatSeptember 26, 2025 | msn.comPresident Trump's 100% Tariff Threat: What It Means For Your Pharma PortfolioSeptember 26, 2025 | seekingalpha.comTrump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a HitSeptember 26, 2025 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?September 22, 2025 | zacks.comPPH: Excellent Pharmaceutical ETF, But Bad Timing To InvestSeptember 18, 2025 | seekingalpha.comMarkets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff BlitzAugust 9, 2025 | moneymorning.comMShould You Invest in the VanEck Pharmaceutical ETF (PPH)?July 22, 2025 | zacks.comJ&J rallies big pharma after earnings despite Trump’s latest tariff threatJuly 16, 2025 | msn.comPPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And CenterJuly 7, 2025 | seekingalpha.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6069July 1, 2025 | msn.comGlobal pharma stocks down as Trump renews tariff threatJune 17, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?May 21, 2025 | zacks.comPPH, Big Pharma Stocks Volatile on Trump Drug PricingMay 14, 2025 | finance.yahoo.comETFs on the Move Post U.S.-China Trade DealMay 12, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025October’s Top 5 Stocks Poised for Big BreakoutsBy Thomas Hughes | October 1, 2025Are Airline Stocks Ready for Takeoff After a Turbulent 2025?By Chris Markoch | October 5, 2025Delta Air Lines Stock Looks Ready to Fly to New HighsBy Thomas Hughes | October 13, 2025PPH, DAL, EZH, and SSTY Company DescriptionsDelta Air Lines NYSE:DAL$62.00 +0.73 (+1.19%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.VanEck Pharmaceutical ETF NASDAQ:PPH$92.21 +0.36 (+0.39%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability 3 Healthcare Companies Insiders Are Buying Tempus AI Hits $100—Are Shares Due for a Pullback? NVIDIA Analysts Lift Targets: What It Means for the Stock Price Fastenal Stock Pulls Back in October—Is It Time to Buy FAST? 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise Why Congress Is Buying Intuitive Surgical Ahead of Earnings D-Wave: Reevaluating the Short Seller’s Case After the Downgrade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
